10 April 2017
The March edition of the Pharmaceutical Executive features a brief piece with Linesight CEO, Gerard Campbell. The life sciences sector has been our fastest-growing sector globally over the last five years and we continue to see future growth in the area. Gerard discusses the evolving role of Project Controls in Pharma projects, as clients look for increased schedule and financial governance, driven from a risk and opportunity approach across their construction portfolio.
Read the full feature here, on page S10 (navigate to page 40).
Share
Related News
23 May 2023
Linesight Q1 2023 Commodity Reports
15 February 2023
Linesight Q4 2022 Commodity Reports
14 February 2023
Linesight Life Sciences Benchmarking Webinar Recording